Apyx Medical (APYX) Stock: Buy, Sell, or Hold?
APYX - Apyx Medical Corporation Common Stock
$2.51
0.07 (2.87%)
▲
5d:
-2.33%
30d:
-14.92%
90d:
-34.46%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When APYX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: APYX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: APYX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: APYX is currently trading at $2.51, which is considered slightly low relative to its 30-day fair value range of $2.47 to $2.91.
Technical Outlook: Technically, APYX is in a strong downtrend. Immediate support is located at $2.34, while resistance sits at $2.73.
Market Sentiment: APYX scores 80/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.50 (+159.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, APYX is in a strong downtrend. Immediate support is located at $2.34, while resistance sits at $2.73.
Market Sentiment: APYX scores 80/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $6.50 (+159.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.47 -
$2.91
Company Quality Score
60/100
(BUY)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- BULLISH: Strong technical setup (80/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 159.0% below Wall St target ($6.50)
- BULLISH: Bottoming setup score 80/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$2.47 -
$2.91
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.36
(14.4%)
Support & Resistance Levels
Support Level
$2.34
Resistance Level
$2.73
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.97
Wall Street Target
$6.50
(+159.0%)
Revenue Growth (YoY)
22.1%
Profit Margin
-14.8%
Share & Embed Analysis
Last updated: October 22, 2026 12:25 AM ET
Data refreshes hourly during market hours. Next update: 1:25 AM
Data refreshes hourly during market hours. Next update: 1:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APYX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 50 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
